Visalytics
Visalytics
approved EB-2 (NIW)

Research Associate

Biostatistics · China · 2025-02-27

Processing Time
151 days
Decision Date
2025-02-27
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to refine statistical methodologies for experimental and observational studies to improve the quality of clinical data interpretation. Her work focuses on enhancing the reliability of healthcare research across various disease contexts, specifically ensuring that real-world evidence from large-scale datasets is evaluated with scientific rigor.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor ensures American patients benefit from healthcare informed by robust data and bolsters the credibility of therapeutic interventions.

2 Well-positioned to Advance the Endeavor Met

The petitioner demonstrated readiness through 13 peer-reviewed articles, 409 citations, and funding from prestigious institutions like the FDA.

3 Balance of Interests Met

It was determined that the U.S. healthcare system benefits significantly from the petitioner's tools for accurate public health and policy decisions.

Why This Petition Was Approved

The petition was approved based on the petitioner's 13 peer-reviewed journal articles, 11 conference abstracts, and 409 citations. Her work received significant funding from major agencies including the FDA and the National Heart, Lung, and Blood Institute, satisfying the Dhanasar prongs for national importance and being well-positioned.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Conference Presentations
Reference Letters Dependent
Government Alignment

Similar Cases

Research Scientist

Research and Development · China

WeGreened EB-2 (NIW) approved
New Jersey 367 days 2022-04-05
The petitioner proposes to develop and apply novel statistical methodologies to more accurately evaluate healthcare data and improve treatment efficacy. Her work focuses on characterizing the mechanisms for conditions such as cancer and COVID-19 to improve global treatment strategies.
View Case

Statistician

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
New Jersey 50 days 2025-03-09
The petitioner proposes to enhance the design and analysis of clinical trials through advanced statistical methodologies and machine learning. His work focuses on creating innovative tools that optimize clinical trial accuracy and accelerate therapeutic approvals for oncology, cardiovascular diseases, and infectious diseases. This endeavor aims to improve public health outcomes by ensuring regulatory compliance and addressing safety evaluation challenges in complex medical conditions.
View Case

Postdoctoral Researcher

Research and Development · China

WeGreened EB-2 (NIW) approved
North Carolina 7 days 2024-07-22
The petitioner proposes to research methods for integrating and analyzing multiple high-dimensional datasets from clinical trials, electronic health records, and large distributed research networks. This work aims to enhance diagnostic accuracy, personalize treatment plans, and address public health disparities by strengthening the data yielded by clinical studies.
View Case

General Manager

Research and Development · China

WeGreened EB-2 (NIW) approved
Washington 390 days 2025-02-05
The petitioner proposes to develop novel statistical approaches to facilitate drug development, healthcare, and pandemic prevention for public health improvement. This includes drafting statistical analysis plans and protocols for clinical trials, as well as implementing statistical techniques for primary endpoints analysis and data monitoring.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-27.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 151 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist